Merck, Endocyte to partner; drug gets virility warning
The FDA adds warning about sexual side effects to Propecia, a drug used to treat baldness.
Separately, Propecia, one of Merck's drugs used for the treatment of baldness, may cause sexual side effects, according to the Food and Drug Adminstration.
The FDA has ordered Merck to change its labels disclosing potential sexual side effects in men who take it. Merck is one of the largest pharma companies with operations in four segments: pharmaceutical, animal health, consumer care and alliance segment. It has a market cap of $115 billion and competes with other health-care companies like Pfizer (PFE), Johnson & Johnson (JNJ) and Abbott Labs (ABT).
Partnership with Endocyte
Merck is about to lose the patent for its allergy and asthma drug, Singulair, and hence is pushing toward bringing new drugs to the market. To this end, Merck is partnering with Endocyte, which is developing Vintafolide, a promising drug for late-stage ovarian cancer.
It has already paid $120 million upfront to Endocyte for developing and marketing the drug. And it has committed another $880 million of payments on milestone achievements.
Merck is also planning to evaluate the drug's effectiveness for other cancer types. This will earn revenues for the oncology segment of Merck and improve its market share and should also offset the loses due to Singulair. Oncology and respiratory drugs contribute nearly 2.4% and 6.3% to the $41.15 Trefis price estimate for Merck.
Baldness drug may cause erectile dysfunction
Merck markets two drugs Proscar and Propecia that contain an active ingredient Finasteride, which has been linked with potential sexual side effects like erectile dysfunction. The FDA has asked for label changes for both drugs to notify the adverse side effects to consumers.
Merck reports revenues from these two drugs under the Legacy Pharma, Animal & Cons. Health Division, which contributes nearly 22% to the company value. If sales from these two drugs drop, Merck will lose market share in this segment, which could impact its share price.
I took Propecia for two months last year. The side effects were horrible. I almost completely lost my sex drive. Never lost my erection but I could see it happening eventually. I'd rather be bald than take that crap!
But now I understand women a little better. I never understood not wanting to have sex until that episode. Now I get it.
Imagine, that full head of hair gets you that model's attention, and you have a limp noodle! I'd stick to the regular gals and show them a good time.
Newsweek and Time sometimes run ads for drugs that cover four pages of small print, mostly side effects, including possible death. Even CVS generic aspirin (99 cents for 125) has warnings on the label, including mixing with alcohol.
Gee,you get some hair so the chicks will want you,but you can't get it up.What a kicker!!
then again,it doesn't matter how your noodle is if she doesn't like bald men..........
Copyright © 2014 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
Remy Cointreau says it was 'adversely affected' by China's anti-extravagance policy.
VIDEO ON MSN MONEY
Top Stocks provides analysis about the most noteworthy stocks in the market each day, combining some of the best content from around the MSN Money site and the rest of the Web.
Contributors include professional investors and journalists affiliated with MSN Money.
Follow us on Twitter @topstocksmsn.